The OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test is FDA-approved for use with oral fluid, fingerstick or venous whole blood and plasma and delivers accurate results in 20 minutes.

CDC guidelines call for routine testing in all healthcare settings to identify all HIV positive people and connect them to care. Prior to rapid HIV testing, most people took a blood-based test that was sent out to an independent laboratory that took 7 to 14 days to process before receiving results. The key advantage of rapid HIV testing is that 100 percent of people may receive their results on the spot and can be linked to care.

This simple and accurate test is ideal for screening programs in public health and outreach settings, emergency departments, labor and delivery, laboratories and physician offices.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physician offices, and commercial and industrial entities.

For more information on the Company, please go to